Table 1 Comparison of group 1 and group 2 patients
Patient characteristics | Group 1 (n = 6) | Group 2 (n = 15) |
|---|---|---|
Mean age, years | 56 | 57 |
Percentage of female patients | 77 | 77 |
Percentage of patients with rheumatoid arthritis | 77 | 53 |
Mean anti-HBsAb titre, IU/L | 302 | 753 |
Mean duration of disease, years | 13 | 10 |
Mean duration of treatment, months | 34 | 24 |
Association with methotrexate (mean dosage: 10 mg/week) | 4 | 6 |
Association with corticosteroid | 1 | 4 |
Two successive anti-TNFα inhibitors | 2 | 4 |
Three successive anti-TNFα inhibitors | 0 | 2 |